Sound familiar fellow Potriotes? The drug is approved in Quebec, but not as first-line therapy. There has to be a recurrence before the Quebec insurance board will cover the drug costs. Faced with that choice, Labelle personally contacted the drug manufacturer to see if he could pay for the drug himself. He negotiated two cycles of treatment from January to June at the cost of $20,000. The treatment worked. montrealgazette/touch/story.html?id=10267593&utm_source=dlvr.it&utm_medium=twitter “I figure I bought myself three more years of life,” Labelle said. “But what about people who can’t afford to pay?”
Posted on: Mon, 06 Oct 2014 23:20:30 +0000
Trending Topics
Recently Viewed Topics
© 2015